Biostatistics is at the core of every clinical trial. Study sponsors rely on biostatistical skill sets involving study design, analysis, and computational experience to deliver on the goals of clinical trials and observational studies. A strong statistical approach to studies generates the high-quality data required to address key objectives and endpoints. The use of biostatistics in public health helps ensure optimal outcomes.

Biostatistics is our legacy and our future

Emmes can help you by providing sound strategic, scientific and statistical input to clinical research. To improve your study’s functioning (e.g., sample size, design parameters), our experienced professionals conduct simulations in clinical trial settings as part of our biostatistics services to help optimize your trial design and performance. We seek to collaborate with you, proposing advanced statistical approaches, innovative study designs and sophisticated analytical methodologies — and build them into your trial Statistical Analysis Plan.

When your trials require the analysis of large volumes of genomic, proteomic, transcriptomic, metabolomic and other “omics” data analysis, our biomedical data science & bioinformatics colleagues can deliver a variety of solutions, including machine learning, advanced data visualization, clinical trial data management, pathways analysis, scalable cloud computing and reproducible data analysis methods. Our expertise in this area has helped our clients advance rare disease research and provide better treatment for patients.

Emmes statistical services are protocol, study and CRF design, randomization, data analysis, regulatory support and reporting

Our shared goal is to optimize your trial, data quality and study results. From initial study planning to protocol writing, study design through regulatory submissions and publications, you can rest assured that Emmes biostatisticians will be with you each step of the way during a clinical trial.


Biostatistics Experience

Emmes was founded by biostatisticians in 1977, and we have since been a “statistics-driven” CRO. There are approximately 80 statisticians at Emmes, with over thirty at the Ph.D. level. Many of us have long tenure with Emmes, averaging more than eight years of service. That has helped create the “brainiac” and collaborative culture that exists inside our walls — a culture we aim to share with clients.

Integrating biostatisticians from clinical trial design through execution and reporting

We have managed biostatistics for over 1,000 clinical trials, from simple Phase I-II to highly complex, global Phase II-IV trials and registries. While we have experience across numerous therapeutic areas, our team has specialized expertise in vaccines, infectious diseases, substance use disorder, neurology/mental health, ophthalmology, oncology, maternal and child health, transplant, allergies, autoimmune disorders and gene/cell therapies.

Contact Us

Biostatistics Leaders

You demand accountability and ownership from your CRO biostatistical team, and we are pleased to provide you with access to our team leaders and experts. We look forward to chatting with you about your studies and our shared passion for biostatistics for the biological and health sciences.

Marian Ewell, Sc.D.

Marian Ewell, Sc.D.

Chief Scientific Innovation Officer

Peter Dawson, Ph.D.

Senior Vice President, Biostatistics